# Pharmacokinetics and Safety of Ertapenem in the Postpartum Period

> **NCT01587495** · PHASE1 · TERMINATED · sponsor: **Daniel Benjamin** · enrollment: 3 (actual)

## Conditions studied

- Endometritis

## Interventions

- **DRUG:** Ertapenem

## Key facts

- **NCT ID:** NCT01587495
- **Lead sponsor:** Daniel Benjamin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** study terminated due to low subject accrual
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587495, "Pharmacokinetics and Safety of Ertapenem in the Postpartum Period". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01587495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*